Browse Appetite depressants topic

Subtopics (16)

Articles

1-95 out of 95 article(s)

Title	Author	Type	Date	Words
In the market for a diet plan? A few pitfalls to avoid.			May 1, 2011	1550
Salamander Cookshop is now Importing Hand-Crafted Zeller Keramik Tableware Direct From Germany.			Aug 17, 2009	403
Kelp help for unsatisfied slimmers.		Brief article	May 2, 2009	159
Wacom, Despec sign distribution deal.			Mar 25, 2009	278
SensaSlim or InstaBone?		Brief article	Nov 1, 2008	253
Dexatrim Max Complex 7.			Nov 1, 2008	88
PPG Acquires Coatings Manufacturer Vanex, Inc.			Jul 15, 2008	238
Meridia Audience Response Introduces Get Feedback(TM) from PowerPoint.			May 16, 2008	446
Why a 100% effective diet pill would lead to a health catastrophe.	Faloon, William	Viewpoint essay	Mar 1, 2008	2816
Diet pills doctor is suspended for a year.			Dec 13, 2007	371
Redux Beverages Announces a New Energy Drink: Brawndo: The Thirst Mutilator.			Nov 27, 2007	466
Less (shar-)pei, more grey(hound).	Bell, John R.	Brief article	Feb 15, 2007	93
Rimonabant enhanced weight loss success, improved lipids.	Moon, Mary Ann	Drug overview	Apr 1, 2006	610
A future shaped by new product development: appetite suppressants, detox foods and products that claim to cure ailments could change the face of the market.		Brief Article	Dec 4, 2004	310
Leptoprin lies.		Brief Article	Sep 1, 2004	198
Converting the carbs.			Feb 7, 2004	116
Something to sniff at. (Indications).	Berger, Joanne M.	Brief Article	Jun 1, 2003	181
Drug pipeline fat with weight-loss medications: perhaps 100 agents in development. (Clinical Rounds).	Kirn, Timothy F.		Apr 1, 2003	821
Effect of a caffeine/ephedra mixture on voluntary physical activity and body weight in mus musculus.	Davis, Matthew R.	Brief Article	Jan 1, 2002	225
Simmondsin From Jojoba Checked for Appetite Suppression.	McGraw, Linda	Brief Article	Dec 1, 2000	408
Beware Long-Term Effects of Antidepressants.	ZWILLICH, TODD	Brief Article	Oct 1, 1999	536
Ergo Science Completes Enrollment of Phase II Weight Loss Clinical Study in Obese Subjects.			Jul 21, 1998	922
Regeneron Receives $5 Million Milestone From P&G Related to Collaboration On Obesity Associated With Diabetes.			Jul 1, 1998	903
Millennium Achieves Research Milestone in Obesity			Jun 30, 1998	814
AMBI Reports Clinical Study Confirms That Chromium Picolinate Aids in Fat Loss.			Jun 23, 1998	739
Voyager Debuts Stabilizer, A Revolutionary Formula Emphasizing the Profound Importance of Stable Blood Sugar Levels in Successful Weight Loss.			Jun 10, 1998	437
Knoll Pharmaceutical Company Statement About FDA Action Regarding Xenical(R) (orlistat)			May 14, 1998	631
Ergo Science Announces Completion of $10 Million License Fee by the R.W. Johnson Pharmaceutical Research Institute.			Apr 16, 1998	757
The fen-phen summer: weight loss brings unexpected results.	Plutowski, Shelly		Apr 1, 1998	1062
Wyeth-Ayerst Provides Background Information on Redux And Pondimin and Current Redux Clinical Studies			Mar 31, 1998	1091
SmithKline Beecham and Ligand Add Leptin-Obesity Research to Existing Collaboration			Mar 18, 1998	1036
Ergo Science and Johnson & Johnson Form Worldwide Collaboration Agreement On Ergo Science's Products for Type 2 Diabetes and Obesity.			Feb 24, 1998	1222
Knoll Pharmaceutical Company Begins Nationwide Distribution of New Anti-Obesity Agent, MERIDIA.			Feb 12, 1998	2286
'Fen-phen' lawsuits build momentum.	Haman, John		Jan 26, 1998	1323
Wyeth-Ayerst States it Acted Responsibly With Diet Drugs			Dec 11, 1997	353
Neurogen Updates NPY Obesity Program			Dec 8, 1997	635
Knoll Pharmaceutical Company Receives FDA Clearance to Market MERIDIA(R); Company Focuses on Appropriate Use of New Drug for Weight Management			Nov 24, 1997	1577
Wyeth-Ayerst Announces Membership of Cardiovascular Assessment Expert Panel			Nov 5, 1997	594
Cocaine trips brain appetite suppressor.	Travis, John	Brief Article	Nov 1, 1997	369
Amended Complaint Seeking Class Action Status Filed Against Manufacturers of Diet Pills Marketed as Fen/Phen and Redux			Oct 30, 1997	368
Kaplan, Kilsheimer & Fox LLP Notice of Fen-Phen/Redux Consumer Class Actions			Oct 13, 1997	365
Additional Consumer Class Actions Filed Against "Fen/Phen" and "Redux" Manufacturers.			Oct 10, 1997	507
Bristol-Myers Squibb and Karo Bio Enter Collaboration; Partnership to Develop New Treatments for Obesity and High Cholesterol			Oct 9, 1997	624
First Georgia Class Action Files Against Makers of Fen/Phen Diet Drugs.			Sep 23, 1997	301
PhenTrim Gears Up for Increased Demand as Consumers Seek Safe Alternatives to Banned Phen-Fen and Redux.			Sep 23, 1997	530
Class Action Commenced Against Manufacturers of Diet Pills Marketed as Fen/Phen and Redux			Sep 23, 1997	433
TOPS Club, Inc., the Leading Non-Profit Weight-Loss Support Group, Offers Tips and Support to Redux and Fen-Phen Patients			Sep 17, 1997	494
FDA Bans Redux and Fen-Phen Combination: French Team of Doctors Offer Natural Product to Control the Desire to Snack			Sep 17, 1997	424
Voluntary Recall of Pondimin and Redux to Impact Earnings for 1997 and 1998			Sep 15, 1997	393
Pondimin(R) and Redux(TM) to be Voluntarily Withdrawn			Sep 15, 1997	1347
FDA Denies Citizen Petition Regarding REDUX			Sep 11, 1997	728
Mayo Plans Follow-up Fen-Phen Study.			Aug 27, 1997	436
Genetic Evolutionary Nutrition Unveils New Product: The Highly Anticipated PYRUVATE BURN With DHA.			Aug 14, 1997	392
First TONALIN CLA Clinical Trial Results Show 20 percent Reduction in Body Fat Percentage.			Jul 30, 1997	604
Wyeth-Ayerst to Add Information to Labeling of Antiobesity Therapies			Jul 25, 1997	635
Genetic Evolutionary Nutrition unveils GEN-FEN, a 100 percent natural herbal Phen-Fen.			Jun 30, 1997	403
Amgen announces leptin causes weight loss in humans and plans for two Phase 2 trials.			Jun 16, 1997	906
Knoll Pharmaceutical Company Statement Regarding FDA Advisory Panel Meeting for Xenical(R) (orlistat)			May 14, 1997	283
Millennium and Roche Report Publication in the Journal Diabetes on the Discovery of a Gene Implicated in Weight Modulation			Apr 25, 1997	1239
Inaccurate AP News Report On Redux Anti-Obesity Therapy; FDA Acknowledges Error and Reaffirms Redux Safety Profile			Apr 22, 1997	1063
Herbalife International Inc. comments on 1996 results.			Jan 31, 1997	150
Herbalife International Inc. announces Hughes securities transaction.			Jan 31, 1997	478
Millennium/Roche Collaboration Results in the Identification of a Novel Weight Regulation Pathway			Jan 8, 1997	1293
Herbalife commences operations in South Korea.			Nov 19, 1996	326
Marinol Found Promising in Treatment of Geriatric Patients with Alzheimer's			Nov 19, 1996	537
Knoll Pharmaceutical Company Receives FDA Approvable Letter for MERIDIA			Nov 11, 1996	466
Lilly and Neurocrine Enter Into Collaboration and CoPromotion Agreement for Research and Development Targeting Obesity and Alzheimer's Disease			Oct 21, 1996	830
Wilshire Technologies Announces Sale of Transdermal Products Business			Oct 2, 1996	278
Interpreting The Latest Research On The Increased Risk To Lungs From Dexfenfluramine			Sep 11, 1996	1167
Neurogen Reports Interim Results of Phase I Clinical Trial for Obesity Drug, NGD 95-1			Aug 26, 1996	661
AMERICAN PHYTOTHERAPY RESEARCH LABORATORY SETS STANDARDS FOR SAFE AND EFFECTIVE USE OF MA HUANG			Jul 17, 1996	306
SCIENTISTS DISCOVER 'FEEDING' RECEPTOR			Jul 10, 1996	955
PHYSICIANS NOW ARMED WITH NEW DRUG TO TREAT OBESITY			Jun 13, 1996	1064
HOUGHTEN PHARMACEUTICALS, INC. INITIATES PHASE II CLINICAL TRIAL FOR DIABETES AND OBESITY			Apr 30, 1996	484
FDA clears Redux [dexfenfluramine] for marketing to treat obesity.			Apr 29, 1996	976
FDA CLEARS REDUX (DEXFENFLURAMINE) FOR MARKETING TO TREAT OBESITY			Apr 29, 1996	1024
NEW WEAPON IN WAR AGAINST FAT			Apr 29, 1996	1182
NEUROGEN COMMENCES HUMAN CLINICAL TRIALS OF NEW ANTI-OBESITY DRUG			Mar 4, 1996	406
MILLENNIUM PUBLISHES THAT LEPTIN RECEPTOR GENE AND db GENE ARE THE SAME; FINDING TRIGGERS MILESTONE PAYMENT BY HOFFMANN-LA ROCHE			Feb 9, 1996	779
Revolutionary weight-loss system launched: New Reliv Celleboost(TM) features CitriMax(R) & other fat-fighting ingredients.			Jan 31, 1996	353
NEUROGEN FILES IND ON NEW ANTI-OBESITY DRUG			Dec 14, 1995	448
NEUROGEN AND PFIZER COMPLETE AGREEMENT FOR ANTI-OBESITY DRUG COLLABORATION			Nov 30, 1995	267
Herbalife reports 1995 third-quarter results.			Oct 27, 1995	988
FDA Advisory Committee to resume meeting for dexfenfluramine on Nov. 16.			Oct 3, 1995	217
Coming: drug therapy for chocoholics?	Raloff, Janet	Brief Article	Jun 17, 1995	497
A weighty problem resolved at last?	Brown, Edwin W.		Jun 1, 1995	524
WILSHIRE TECHNOLOGIES ANNOUNCES TRANSDERMAL PRODUCT APPROVAL			May 17, 1995	171
REVOLUTIONARY NEW FAT LOSS CAPSULE AVAILABLE			Apr 18, 1995	234
Herbalife agrees to lawsuit dismissal.			Apr 3, 1995	180
VITAMIN SPECIALTIES ANNOUNCES EXECUTION OF JASON ACQUISITION AGREEMENT AND TWO NEW JASON PROGRAMS			Dec 14, 1994	228
WILSHIRE TECHNOLOGIES ANNOUNCES SECOND QUARTER RESULTS			Jul 18, 1994	491
INTERACTIVE MEDICAL ENTERS TECHNOLOGY LICENSING AGREEMENT			Mar 24, 1994	218
NEWAYS INC. RECALLS 'QUICKLY' WEIGHT-LOSS PRODUCT, ACCORDING TO FDA			Nov 12, 1993	407
Coffee-an appetite depressant.	Lee, Samuel	Column	Oct 1, 1991	1163
Sweet news on hunger suppression....			Mar 24, 1990	306